相关实验视频

Updated: Jul 10, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

缺氧和互白素-1-原料介酶干细胞/流体细胞作为中风的新疗法

Maryam Adenike Salaudeen^1,2, Stuart Allan¹, Emmanuel Pinteaux³

¹Faculty of Biology, Medicine, and Health, Division of Neuroscience, University of Manchester, Manchester, UK.

|November 21, 2023

概括

介质细胞干细胞/细胞 (MSCs) 对中风治疗有前途,但存在缺点. 用低氧和互白素-1进行MSC的初始化可以增强其益处并克服限制,以获得更好的临床成功.

科学领域:

神经科学是一个神经科学.
再生医学是一种再生医学.
干细胞生物学干细胞生物学

背景情况:

临床前中风研究往往在临床试验中失败,需要改进临床前研究设计.
再生医学,特别是介质干细胞/脑干细胞 (MSCs),越来越多地被用于中枢神经系统 (CNS) 疾病,如中风.
由于可用性和差异化潜力,MSC与其他干细胞相比具有优势.

研究的目的:

审查后缺血性中风 (IS) 的分子和细胞变化.
讨论MSCs适合解决IS相关变化的问题.
识别IS处理中的MSC缺点,并提出优化策略.

主要方法:

文献综述侧重于临床前中风研究和MSC应用.
在缺血性中风后分子和细胞事件的分析.
评估MSC的特性,局限性和原始化技术.

主要成果:

缺血性中风会诱导大脑中的特定分子和细胞变化.
多重神经细胞具有有利于中风恢复的特性,包括分化为神经和免疫细胞.
确定了MSCs用于IS治疗的主要缺点.

结论:

通过原始化优化MSC,特别是低氧和互白素-1,可以增强其治疗潜力.
解决MSC的局限性对于治疗缺血性中风的成功临床转化至关重要.
使用优化MSC的精细的临床前策略可能会改善中风的临床试验结果.

关键词:

氧气过低是因为缺氧.缺血缺血是因为缺血.中介细胞干细胞/中介细胞干细胞启动启动启动一次性中风,中风.

更多相关视频

Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model

Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model

Published on: November 21, 2019

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

相关概念视频

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...